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Higher-dose,higher-repetitionupper limbmotorrehabilitationprogramafter stroke
is not superior to dose-matched or usual-dose customary occupational therapySynopsisSummary of: Winstein CJ, Wolf SL, Dromerick AW, Lane CJ, Nelson MA,
Lewthwaite R, et al, for the Interdisciplinary Comprehensive Arm Rehabili-
tation Evaluation (ICARE) Investigative Team. Effect of a task-oriented
rehabilitationprogramonupper extremity recovery followingmotor stroke.
The ICARE randomized clinical trial. JAMA. 2016;315:571-581.
Question: Does intensive, high-repetition, task-oriented training
during outpatient rehabilitation improve upper extremity motor function
after stroke compared to dose-equivalent usual occupational therapy or
conventional (low-dose) occupational therapy. Design: Phase 3, parallel 3-
group, assessor-blinded, randomised, controlled trial with stratiﬁcation
by motor severity and time from stroke onset. Setting: Seven sites
(predominantly inpatient rehabilitation). Participants: Individuals who
were an average of 46 days post stroke (SD 22) with moderate upper limb
motor impairment. Key exclusion criteria were severe cognitive and
sensory impairments. Randomisation of 361 patients allocated 119 to the
Accelerated Skill Acquisition Program, 120 to receive dose-equivalent
usual and customary occupational therapy care, and 122 to receive
observation only (low-dose) customary occupational therapy. Interven-
tions: The Accelerated Skill Acquisition Program, which was delivered
three times perweek for 1 hour per session for 10weeks, was an intensive,
task-speciﬁc intervention in which purposeful movement was empha-
sised; constraint of the less affected hand was optional. Dose-equivalent
usual and customary occupational therapy care received usual and
customary care at the same dose as the Accelerated Skill Acquisition
Program intervention. The observation only (low-dose) customary
occupational therapy was a usual-care group, where the dose was not
manipulated. Outcome measures: The primary outcome measure was
change in log-transformed Wolf Motor Function Test time score at
12 months. Secondary outcome measures were change in Wolf Motor
Function Test time (minimal clinically important difference: 19 seconds)
and the proportion of participants who increased by at least 25 points on1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).the hand subscale of the Stroke Impact Scale. Results: Eighty-four percent
of patients (n = 306) completed the study with no signiﬁcant difference in
attrition between groups. The mean between-group differences in the log-
transformed Wolf Motor Function Test time score at 12 months were not
statistically signiﬁcant: the Accelerated Skill Acquisition Program versus
dose-equivalent usual and customary occupational therapy care was
0.14 log-transformed seconds (95% CI –0.05 to 0.33); the Accelerated Skill
Acquisition Program versus observation only (low-dose) customary
occupational therapywas –0.01 (95% CI –0.22 to 0.21); the dose-equivalent
usual and customary occupational therapy care versus Accelerated Skill
AcquisitionProgramwas–0.14 (95%CI–0.32 to0.05). Thesebetween-group
meandifferences corresponded to small changes inabsolute values, ranging
from 0.5 to 2.0 seconds. Across all participants, the mean improvement in
Wolf Motor Function Test time over 12 months was 6.8 seconds (95% CI
5.3 to8.3). Theproportionofpatients ineachgroupwithhand functionscale
improvement ( 25 points) was 73%, 72% and 69%, respectively, with no
between-group differences. Conclusion: Providing a structured and
intensive (27 hours) upper limb motor rehabilitation program was not
superior to usual occupational therapy (either dose-equivalent or lowdose,
11 hours). Moreover, mean improvements did not exceed clinically
meaningful thresholds in upper limb motor function.
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ociation. This is an open access article under the CC BY-NC-ND license (http://The ICARE trial investigated an Accelerated Skill Acquisition Program
(ASAP), which was a structured, task-oriented rehabilitation program that
focused on eight key principles of motor training after stroke. Importantly,
the ASAP was compared to usual and customary care that was of an
equivalent dose or a usual dose. These comparison groups enabled content
anddose of rehabilitation onupper limbmotor recovery to be disentangled.
While the majority of participants in the ICARE trial demonstrated an
improvement in upper limb function at theprimary end-point (12months),
there was no beneﬁcial effect in favour of ASAP over and above the
comparison groups. Thus, it would appear that the time-dependent
component of motor recovery was unchangeable by content or dose of
rehabilitation performed. It is possible that an individual’s underlying
neurobiology played a role in their recovery trajectory. However, therewas
no report of a biomarker of stroke recovery,1 which would have enabled
investigation of whether rehabilitation can only get you so far if you have
reduced connection between the brain and upper limb.
Theoutcomesof this trial areconsistentwithagrowingbodyof evidence
that demonstrates a lack of superiority of higher intensity, task-oriented
rehabilitation over and above usual care for people with upper limb
impairment after stroke.2,3 This suggests thatweare yet to identifywhat the
critical active ingredients of upper limb rehabilitation are from the inactive
ingredients.4 Key questions that remain about possible active ingredients as
a result of this trial centre on: 1) Dose and frequency:was a 1-hour session,three times per week for 10 weeks sufﬁcient to shift an individual’s long-
term recovery trajectory? 2) Active time: was there sufﬁcient time spent
during a session actively engaging compared to rest? 3) Challenge: was an
optimal challenge point sustained for the entire duration of a therapy
session? 4) Real-world use: was there sufﬁcient use of the upper limb in
environmentsoutside theclinic?Asaprofession,wecanallwork together to
reﬁne our understanding of these possible active ingredients by collectively
pooling data and collaborating across research and clinical settings.
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